Clarity AI Acquires ecolytiq, Further Expanding Its AI Sustainability Solutions to End Consumers
9.7.2025 13:00:00 CEST | Business Wire | Press Release
Clarity AI, one of the world’s largest and most awarded technology and AI firms in sustainability, today announced the acquisition of ecolytiq, a leading provider of in-app climate engagement solutions for financial institutions and their millions of retail and commercial banking customers globally. This strategic move further reinforces Clarity AI’s position at the forefront of the rapidly expanding sustainability tech sector, strengthening its dominance in delivering impactful, data-driven solutions that empower individuals and organizations to make more sustainable choices.
With this acquisition, Clarity AI expands its class-leading product portfolio, serving a broad spectrum of market participants—from institutional investors and global corporations to retail banks and individual consumers. The company’s modular, AI-powered platform is designed to embed sustainability intelligence into every decision at scale, transforming complex data into actionable insights that drive responsible consumption and investment.
ecolytiq’s platform, now part of Clarity AI’s suite, specializes in analyzing real-time transaction data to quantify environmental footprints and deliver high-impact sustainability content, powered by behavioural science and designed for measurable impact. Its white-label solutions have enabled banks and financial institutions across Europe and beyond to engage millions of consumers and business clients, fostering climate-positive behavior change through timely and compelling insights. Notably, this has been amplified through ecolytiq’s long-term strategic partnership with Visa, a world leader in digital payments with approximately 14,500 financial institution clients worldwide. As part of the acquisition, Visa has become an investor and strategic partner of Clarity AI.
“This acquisition is more than a strategic move; it’s a declaration of intent,” said Rebeca Minguela, Founder and CEO of Clarity AI. “We are transforming sustainability insights into a catalyst for action. ecolytiq’s platform aligns perfectly with our mission to embed sustainability intelligence into every decision—from multi-billion-dollar portfolios to everyday purchases. Together, we’re setting a new standard for how financial institutions engage consumers with data that drives meaningful change.”
David Lais, Co-Founder and Managing Director at ecolytiq, added: ”ecolytiq was founded with the idea that banking can be a powerful catalyst for climate action. The mission has always been to empower individuals to drive positive climate impact at scale through their everyday purchasing decisions. By joining forces with Clarity AI, we're taking that vision to the next level—combining our behavioral science-based climate engagement technology with a world-class, AI driven sustainability platform. Together, we're accelerating the transition to a greener future—powered by the best available data and backed by purpose.”
Positioning for Growth as a Tech-Driven Sustainability Leader
Clarity AI has established itself as a leader in sustainability intelligence, recognized by Forrester as a Leading Provider for two consecutive reports. The company currently serves a direct network of clients managing approximately $70 trillion in assets, with its influence spanning institutional investors, corporates, and consumers worldwide.
By integrating ecolytiq’s consumer-centric platform, Clarity AI not only strengthens its consumer engagement capabilities, but also expands its reach as a comprehensive, tech-first sustainability provider. With a proven track record of converting complex datasets into actionable intelligence, Clarity AI continues to set the benchmark for how financial institutions, corporations, and investors leverage AI to drive sustainability outcomes at scale.
About Clarity AI
Clarity AI is the leading sustainability tech company, leveraging advanced technology and AI to provide data-driven environmental and social insights to investors, corporates, governments, and consumers. AI has been at the core of Clarity AI's offering from the start, supporting a fully flexible set of data solutions, insights, analytics capabilities, and tools used for portfolio management, corporate research and engagement, benchmarking, regulatory reporting, online banking, and e-commerce. Clarity AI was named a leader by independent research in The Forrester Wave: ESG Data & Analytics, Q3 2024.
Within the investment sector, Clarity AI serves a direct network of clients managing around $70 trillion in assets and includes firms like Nordea and Santander. Our strategic partnerships with financial institutions such as BlackRock, BNP Paribas, Caceis, or SimCorp, allow thousands of users to access Clarity AI advanced data analytics capabilities through their usual investment platforms, ensuring a seamless workflow experience. Clarity AI has offices in North America, Europe, and the Middle East. For more information visit www.clarity.ai
About ecolytiq
ecolytiq enables banks and financial services providers to drive customer engagement through sustainability – creating positive impact for both the environment and business growth. The ecolytiq product suite enriches a traditional banking app with information to understand an individual’s environmental impact, as well as personalized climate insights and actions to help measurably reduce one’s carbon footprint.
Having partnered with leading financial institutions including Visa, TSYS, Tink, HSBC, Piraeus, and Mashreq, ecolytiq operates globally to leverage payment data for a better, more sustainable banking experience.
ecolytiq is proudly a certified B Corporation.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250708448855/en/
Contacts
For any related inquiries, please contact:
Media contact Clarity AI
Aspectus Group
ClarityAI@aspectusgroup.com
Media contact ecolytiq
media@ecolytiq.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom